What Challenges Exist in Targeting Nonsense Mutations?
Despite the potential, several challenges exist in targeting nonsense mutations. One major issue is genetic heterogeneity, where different mutations may exist within the same tumor or among different patients, complicating treatment. Additionally, off-target effects and toxicity are concerns with readthrough drugs and gene editing technologies. Ensuring the specificity and safety of these therapies remains a critical area of research.
